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Subcutaneous injection of dexamethasone resulted in a reduction of demonstrable phosphohpase D activity of rat brain 
and liver microsomes. Partially purified rat lung lipocortin inhibited the activity of both microsomal and partially purified 
rat brain phosphohpase D. These results show that phosphohpase D activity is suppressed by dexamethasone and one 
of the possible mechanisms of inhibition may be a phospholipase inhibitory protein, lipocortin. 
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1. INTRODUCTION 
Phospholipase D (PL-D) of mammalian tissues 
is a membrane-bound enzyme that possesses both 
hydrolytic and transphosphatidylation activities 
[ 11. Mammalian PL-D, which is detectable in all 
tissues examined [2], does not require added 
divalent cations for activity. The synaptic plasma 
membrane has the highest specific activity com- 
pared to other membranes of rat brain [3]. Recent- 
ly, several investigators have suggested that PL-D 
may play a role in the processes of cell activation. 
A variety of Ca2+ -mobilizing hormones were 
reported to result in the accumulation of 
phosphatidic acid via a PL-D mechanism with 
hepatocytes [4]. The release of choline rather than 
phosphorylcholine from phosphatidylcholine by 
cultured cells is stimulated by the tumor- 
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promoting phorbol ester, TPA [5]. TPA also 
stimulates the accumulation of phosphatidyl- 
ethanol in the presence of ethanol in animal cells 
[6]. Phosphatidylethanol can be formed by the 
transphosphatidylation activity of PL-D [7,8]. In 
addition, PL-D may function in providing choline 
for acetylcholine formation in brain [3]. 
Glucocorticoid hormones have a permissive ef- 
fect on the action of other hormones. The anti- 
inflammatory action of glucocorticoid hormone 
may be explained by the induction of phospho- 
lipase A2 inhibitory proteins termed lipocortins 
which in turn block prostaglandin precursor 
release [9]. The lipocortins have been the subject of 
several reviews [lo- 121. Lipocortins can inhibit 
bacterial phospholipase C, cabbage PL-D and 
several soluble phospholipase AZ activities in vitro 
[ 131. We examined the effect of dexamethasone in- 
jection on the PL-D activity and the effect of par- 
tially purified lipocortin on the activity of 
solubilized partially purified PL-D. 
2. EXPERIMENTAL 
Groups of male Sprague-Dawley rats weighing 80-100 g were 
either adrenalectomized (ADX) or sham-operated (NL). The 
completeness of adrenalectomy was confirmed by visual inspec- 
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tion after killing. On the 14th post-operative day some of the 
ADX and NL animals were injected subcutaneously with 
3. RESULTS 
25Opg/lOO g wt of dexamethasone acetate (DEX). Control 
animals were injected with 0.9% NaCl solutions and the 
adrenalectomized animals had 0.9% NaCl in their drinking 
water. The animals were injected for 4 successive days. 24 h 
after the last injection, the animals were fasted overnight and 
then the brain and liver microsomal fraction prepared as in (21. 
Lipocortin was partially purified from rat lung tissue ac- 
cording to [14] and found to possess 2 bands on SDS-PAGE. 
Inhibition of snake venom phospholipase Al activity was 
measured as in [13]. Rat brain PL-D was solubilized and partly 
purified according to a previous procedure [15] and its activity 
assayed as described [ 161. CDP-choline, 1,2-diacylglycerol 
cholinephosphotransferase activity was determined with CDP- 
[‘%]choline as in [17]. Phospholipid N-methyltransferase and 
base-exchange enzyme activities were as previously described 
[ 181. NADPH cytochrome c reductase measurement was as 
described [ 191. 
Statistical evaluation was performed using Student’s l-test. 
The effect of adrenalectomy and dexamethasone 
injections on the activities of the enzymes is shown 
in table 1. As previously reported, phosphatidic 
acid produced by PL-D is capable of being 
hydrolyzed by endogenous phosphatidic acid 
phosphatase to yield diglyceride. Diglyceride for- 
mation was also measured because phosphatidic 
acid phosphatase activity is only partially blocked 
by NaF. Hepatic PLD activity is reduced approx. 
70% in both groups of DEX-treated animals. 
There is only a 40% reduction of the brain activity 
in the ADX-DEX treated animals and 16% in the 
NL-DEX animals. There was a reduction of liver 
phospholipid N-methyltransferase activity in both 
groups of DEX-treated animals when assayed with 
Table 1 
Phospholipase D, phospholipid N-methyltransferase and CDP-choline:choline 
phosphotransferase activity of brain and liver P, fraction from normal, 
adrenalectomized and dexamethasone-treated rats 
Normal NL + DEX ADX ADX + DEX 
(1) PLD 
(1.1) Liver 
PA 15.5 f 0.9 5.3 & 0.6’ 20.1 + 1.0” 
Diglyceride 24.9 t 1.3 6.6 * 1.9’ 17.5 f 0.4h 
PA + diglyceride 40.3 t 0.4 11.8 f 2.5* 37.6 & 1.1 
(1.2) Brain 
PA 52.3 + 1.4 40.3 f 1.0’ 46.1 + 3.1 
Diglyceride 47.2 f 1.9 43.8 ?I 0.8 49.3 * 2.2 
PA + diglyceride 99.4 f 3.4 84.0 -+ 0.2b 95.4 t 5.4 
(2) PMT 
(2.1) Liver 
No addition 37.8 f 1.6 18.0 f 3.6’ 49.1 + 2.9” 
+ PMME 93.1 ?I 5.6 62.2 + 7.5a 98.4 ? 3.7 
(2.2) Brain 
No addition 27 -+8 13 * 9 22 rt4 
+ PMME 27 i7 23 +12 51 +7 
(3) CDP-choline cholinephosphotransferase 
(3.1) Liver 2.2 * 0.2 1.5 ? 0.04” 3.6 + 0.2’ 
(3.2) Brain 1.4 + 0.03 1.4 + 0.01 1.9 k 0.08’ 
(4) NADPH cvtochrome c reductase 
4.9 i O.ld 
8.1 + 1.5’ 
13.0 & I.5d 
34.0 + 0.2d 
27.3 + l.Od 
61.2 ? 0.7d 
9.0 f 1.0d 
37.0 f 3.0d 
16 +4 
37 f6 
1.2 + 0.08’ 
1.8 k 0.04e 
(4.1) Liver 42.7 + 0.4 60.8 + 4.0b 36.0 + 2.5 51.6 f 1.0‘ 
ap<0.05;bp0.02;cp0.01;dp0.001 
PA, phosphatidic acid; PMT, phospholipid N-methyltransferase; PMME, 
phosphatidylmonomethylethanolamine. Data are shown as means + SE of duplicate 
determinations from 3 separate experiments. Enzyme activities were expressed as 
nmol/mg protein per h for PL-D, pmol [3H]CH~ group incorporated/mg protein per 
min for liver PMT, pmol [‘H]CH, group incorporated/mg protein per h for brain 
PMT, nmol/mg protein per min for cholinephosphotransferase and nmol/mg protein 
per min for NADPH cytochrome c reductase 
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Table 2 
Effect of lipocortin on membrane bound and partially purified 
rat brain phospholipase D 
explanation for the reduction of the activity is the 
induction of phospholipase inhibitory proteins 
such as lipocortins which inhibit PL-D. 
Enzyme source PLD activity 
Microsomal (24 pg protein), no addition 129k 4 
+ lipocortin a (15 pg protein) 12 + lb 
+ lipocortin b (7.7 pg protein) 27 i 4h 
Partially purified PLD (3.7 pg), no addition 714 f 50 
+ lipocortin a (15 pg protein) 254 i- 19” 
+ lipocortin b (7.7 pg protein) 248 i 36” 
li p < 0.002; b p < 0.001 
Data are means k SE of duplicate determinations from 3 
separate experiments. Enzyme activities expressed as nmol 
lecithin hydrolyzed/mg protein per h. Lipocortin was partially 
purified according to Shadle et al. [14]. The fractions of DEAE- 
cellulose (lipocortin a) and Sephadex G-100 (lipocortin b) 
column chromatographies were used as partially purified 
Since PL-D may play an important role in cell- 
activation processes by many agents, the change in 
PL-D activity may contribute to the modulation of 
these processes. This alteration of PL-D activity 
conceivably could also affect the level of 
diacylglycerol, a potent activator of protein kinase 
C. We have previously shown that endogenous 
phosphatidylcholine can yield diglyceride upon ac- 
tivation of PL-D [22]. 
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